LOLITA CAMP: Open Payments
NPI 1083782734 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,771 in 25 payments from 12 companies in 2025. Trend: 2023 $1,837 · 2024 $1,899 · 2025 $2,771
Food & beverage: $2,771
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 11 | $974 |
| Madrigal Pharmaceuticals | 2 | $270 |
| AstraZeneca Pharmaceuticals LP | 2 | $243 |
| ViiV Healthcare Company | 2 | $227 |
| Abbott Laboratories | 1 | $163 |
| Medtronic, Inc. | 1 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $140 |
| Alexion Pharmaceuticals, Inc. | 1 | $135 |
| Corcept Therapeutics | 1 | $125 |
| GENZYME CORPORATION | 1 | $125 |
Products named: Epclusa, REZDIFFRA, FREESTYLE LIBRE 3, INTERSTIM, Kerendia, STRENSIQ, Korlym, Descovy.
Industry payments across LA — which companies pay providers there.
